ClinVar Miner

Submissions for variant NM_000368.4(TSC1):c.1921C>T (p.Pro641Ser) (rs374222196)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000163665 SCV000214237 likely benign Hereditary cancer-predisposing syndrome 2017-06-20 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient or conflicting evidence,In silico models in agreement (benign),Co-occurence with a mutation in another gene that clearly explains a proband's phenotype
GeneDx RCV000122190 SCV000243467 likely benign not specified 2018-02-07 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000725780 SCV000339329 uncertain significance not provided 2016-02-12 criteria provided, single submitter clinical testing
Invitae RCV000725780 SCV000552288 benign not provided 2019-03-05 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000725780 SCV000884752 likely benign not provided 2018-06-30 criteria provided, single submitter clinical testing The TSC1 c.1921C>T; p.Pro641Ser variant (rs374222196), to our knowledge, is not reported in the medical literature, but is listed in ClinVar (Variation ID: 135364). This variant is found in the general population with an overall allele frequency of 0.005% (13/27,7182 alleles) in the Genome Aggregation Database, and has a higher than expected frequency in the East Asian population (0.05%, 10/18,870 alleles) based on an estimated prevalence of 1 in 17,400 for TSC1-associated Tuberous Sclerosis Complex (Northrup 2015). The proline at codon 641 is moderately conserved, but computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. In addition, most pathogenic TSC1 variants are null alleles and only rarely (<5%) missense variants (Northrup 2015). Based on available information, this variant is considered to be likely benign. REFERENCES Northrup H, Koenig MK, Pearson DA, et al. Tuberous Sclerosis Complex. 1999 Jul 13 (Updated 2015 Sep 3). In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1220/.
ITMI RCV000122190 SCV000086408 not provided not specified 2013-09-19 no assertion provided reference population

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.